Minerva Neurosciences Stock Skyrockets on $200M Lifeline for Schizophrenia Drug
Stock Soars on Major Funding News Minerva Neurosciences’ stock chart went vertical on Tuesday after the biotech announced an expansive financing deal that effectively triples the company’s market capitalization overnight marketbeat.com. In pre-market trading on Oct. 21, NERV stock jumped as much as 160% on the news gurufocus.com. The shares opened around $6–7 (up from ~$2.66 prior close) and oscillated near those levels through the day, ultimately marking a 52-week high of $6.97 marketbeat.com. By comparison, NERV had traded as low as $1.15 within the past year marketbeat.com, reflecting both the dramatic rebound and the extreme volatility inherent in this